Quest Pharmatech (QPT.V) Stock Price
Quest Pharmatech Price
Revenue at Quest Pharmatech has contracted by 23.7% per year over the past 10 years to 38,871.00 CAD. Quest Pharmatech's net margin stands at -13,084.8%, down from -68.4% several years earlier.
Quest Pharmatech stock price
Quest Pharmatech business model & stock analysis
Frequently asked questions about Quest Pharmatech
Converted at the current exchange rate, the Quest Pharmatech share trades at 0.01 EUR (0.02 CAD).
The revenue cannot currently be calculated for Quest Pharmatech.
The profit of Quest Pharmatech is 5.00 M CAD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Quest Pharmatech is currently 0.68. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Quest Pharmatech stock.
The P/S cannot be calculated for Quest Pharmatech currently.
The Eulerpool Quality Score for Quest Pharmatech is 2/10.
The ISIN of Quest Pharmatech is CA74836M1068. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Quest Pharmatech is QPT.V. The ticker symbol is used to trade Quest Pharmatech shares on the stock exchange.
Quest Pharmatech stock
Quest Pharmatech Peer Group
Quest Pharmatech FIGI
All fundamentals and in-depth analysis of Quest Pharmatech
Our stock analysis for Quest Pharmatech stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Quest Pharmatech. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.